Eidos Therapeutics Archives | GeoInvesting

Eidos Therapeutics

SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD
Gallery
SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD

Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology

SanaCurrents BioTech Research Service Inaugural Reports on EIDX and GLMD

By Bill Langbein|2020-03-11T15:33:54-04:00November 18th, 2018|Categories: Bill Langbein, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: Bill Langbein, Eidos Therapeutics, EIDX, Galmed, GLMD, healthcare, SanaCurrents|

Last week, Galmed Pharmaceuticals (NASDAQ:GLMD) shares climbed as high as [...]

0

Update on Eidos Therapeutics after Positive Phase II Results
Gallery
Update on Eidos Therapeutics after Positive Phase II Results

Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents

Update on Eidos Therapeutics after Positive Phase II Results

By Bill Langbein|2018-12-04T11:25:37-05:00November 12th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: Bill Langbein, Eidos Therapeutics, EIDX, healthcare, SanaCurrents|

Eidos Therapeutics, Inc. (NASDAQ:EIDX) shares are up as much as [...]

0